Fleury deal to acquire women’s health lab Femme approved by Brazil CADE
Fleury’s proposed full acquisition of Femme has been unconditionally approved in Brazil following a nearly five-month review. The nation's antitrust watchdog particularly reviewed horizontal overlaps and vertical integrations, with concerns later...To view the full article, register now.
Already a subscriber? Click here to view full article